These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21510723)

  • 21. [Drug therapy of primary and secondary pulmonary hypertension].
    Olschewski H
    Herz; 2002 Aug; 27(5):463-7. PubMed ID: 12365287
    [No Abstract]   [Full Text] [Related]  

  • 22. Schistosomiasis and pulmonary hypertension.
    Fernandes CJ; Jardim CV; Hovnanian A; Hoette S; Morinaga LK; Souza R
    Expert Rev Respir Med; 2011 Oct; 5(5):675-81. PubMed ID: 21955237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timeline of haemodynamic improvement with subcutaneous prostacyclin therapy in a patient with severe pulmonary arterial hypertension.
    Sadushi-Koliçi R; Perthold W; Fruhwald FM; Lang IM
    Eur J Clin Invest; 2008 Aug; 38(8):603-4. PubMed ID: 18573098
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hemodynamic modifications induced by urapidil in man].
    Bielen E; Fagard R; Lijnen P; M'Buyamba-Kabangu JR; Staessen J; Van Hoof R; Amery A
    Therapie; 1990; 45 Suppl 2():191-7. PubMed ID: 2187267
    [No Abstract]   [Full Text] [Related]  

  • 25. Pulmonary hypertension and erythropoietin.
    Buemi M; Senatore M; Gallo GC; Crascì E; Campo S; Sturiale A; Coppolino G; Bolignano D; Frisina N
    Kidney Blood Press Res; 2007; 30(4):248-52. PubMed ID: 17587864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis.
    Distler O; Behrens F; Huscher D; Foeldvari I; Zink A; Nash P; Denton CP; Humbert M; Matucci-Cerinic M; Seibold J; Rubin L; Furst DE
    Rheumatology (Oxford); 2006 Dec; 45(12):1455-7. PubMed ID: 16920751
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of heptaminol hydrochloride on normal and increased pressure of the pulmonary artery in man. A therapeutic attempt in pulmonary hypertension].
    Plass R; Münster W; Bohm R
    Dtsch Gesundheitsw; 1970 Jul; 25(28):1301-4. PubMed ID: 5511417
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy.
    Dimopoulos K; Peset A; Gatzoulis MA
    Int J Cardiol; 2008 Sep; 129(2):163-71. PubMed ID: 18367267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled iloprost for therapy in pulmonary arterial hypertension.
    Ewert R; Gläser S; Bollmann T; Schäper C
    Expert Rev Respir Med; 2011 Apr; 5(2):145-52. PubMed ID: 21510725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy according to current guidelines. Practical management of pulmonary arterial hypertension.].
    Pabst S; Hammerstingl C; Nickenig G; Skowasch D
    Pharm Unserer Zeit; 2010 Nov; 39(6):448-52. PubMed ID: 20967933
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pulmonary arterial hypertension in collagen disease: findings of the German Network for Systemic Scleroderma].
    Halank M; Seyfarth HJ; Opitz C; Schmeisser A; Ewert R; Höffken G
    Dtsch Med Wochenschr; 2007 Feb; 132(7):337; author reply 338. PubMed ID: 17286224
    [No Abstract]   [Full Text] [Related]  

  • 32. Pulmonary hypertension in heart failure.
    Guglin M; Khan H
    J Card Fail; 2010 Jun; 16(6):461-74. PubMed ID: 20610227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPARgamma activation: a potential treatment for pulmonary hypertension.
    Hansmann G; Zamanian RT
    Sci Transl Med; 2009 Dec; 1(12):12ps14. PubMed ID: 20371457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levosimendan is not effective in reducing pulmonary pressures in patients with idiopathic pulmonary arterial hypertension: report of two cases.
    Cavusoglu Y; Beyaztas A; Birdane A; Ata N
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):503-7. PubMed ID: 19346968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of nifedipine and captopril in children with pulmonary hypertension due to bronchopneumonia.
    Uner A; Dogan M; Demirtas M; Açikgöz M; Temel H; Kaya A; Caksen H
    J Trop Pediatr; 2008 Oct; 54(5):294-9. PubMed ID: 18304952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pulmonary hypertension in sickle cell disease--epidemiology, pathogenesis, diagnosis and treatment].
    Maschmeyer G; Haas A; Dickerhoff R; Kleber FX
    Dtsch Med Wochenschr; 2007 Jan; 132(3):103-7. PubMed ID: 17219345
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulmonary arterial hypertension in the pediatric age.
    Donti A; Formigari R; Ragni L; Manes A; Galiè N; Picchio FM
    J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):72-7. PubMed ID: 17255821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic thromboembolic pulmonary hypertension in pediatric patients.
    Madani MM; Wittine LM; Auger WR; Fedullo PF; Kerr KM; Kim NH; Test VJ; Kriett JM; Jamieson SW
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):624-30. PubMed ID: 20800245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different features of pulmonary hypertension in Rendu-Osler Syndrome.
    Ruiz-Cano MJ; Escribano P; Tello R; Sanchez Nistal A; Flox A; Delgado JF
    Clin Respir J; 2008 Jul; 2(3):191-2. PubMed ID: 20298330
    [No Abstract]   [Full Text] [Related]  

  • 40. Pulmonary hypertension, pulmonary blood vessels and vasoactive drugs.
    Wanstall JC
    Proc West Pharmacol Soc; 1997; 40():137-40. PubMed ID: 9436235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.